Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dalmark

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Anti-Cancer Drugs|August 1, 1994
On-demand antiemetic treatment with the serotonine antagonist tropisetron in cisplatin-treated cancer patientsH Havsteen, L J Andersen, M Kjaer, et al.
Cancer Treatment Reports|December 1, 1987
Prednimustine in advanced malignant melanoma: a phase II studyL Pedersen, J Løber, M Dalmark, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
Pharmacokinetics of doxorubicin in man with induced acid or alkaline urineA Krarup-Hansen, K Wassermann, S N Rasmussen, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Pharmacokinetics of doxorubicin and its metabolite doxorubicinol in rabbits with induced acid and alkaline urineP B Johansen, S E Jensen, S N Rasmussen, et al.
The Journal of General Physiology|February 1, 1973
Characteristics of chloride transport in human red blood cellsR B Gunn, M Dalmark, D C Tosteson, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
Phase I study of 4-demethoxydaunorubicin by oral route in patients with advanced cancerA Krarup-Hansen, E Andersen, K Elbaek, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1989
Oral idarubicin in the treatment of advanced breast cancerL Bastholt, M Dalmark, A Jakobsen, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1990
Weekly oral idarubicin in postmenopausal women with advanced breast cancer. A phase II studyL Bastholt, M Dalmark, A Jakobsen, et al.
Clinical Pharmacology and Therapeutics|June 1, 1989
Pharmacokinetics of oral idarubicin in breast cancer patients with reference to antitumor activity and side effectsK Elbaek, E Ebbehøj, A Jakobsen, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1993
A randomized feasibility study evaluating the effect of radiotherapy alone or combined with 5-fluorouracil in the treatment of locally recurrent or inoperable colorectal carcinomaM Overgaard, K Bertelsen, M Dalmark, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Anti-Cancer Drugs|August 1, 1994
On-demand antiemetic treatment with the serotonine antagonist tropisetron in cisplatin-treated cancer patientsH Havsteen, L J Andersen, M Kjaer, et al.
Cancer Treatment Reports|December 1, 1987
Prednimustine in advanced malignant melanoma: a phase II studyL Pedersen, J Løber, M Dalmark, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
Pharmacokinetics of doxorubicin in man with induced acid or alkaline urineA Krarup-Hansen, K Wassermann, S N Rasmussen, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Pharmacokinetics of doxorubicin and its metabolite doxorubicinol in rabbits with induced acid and alkaline urineP B Johansen, S E Jensen, S N Rasmussen, et al.
The Journal of General Physiology|February 1, 1973
Characteristics of chloride transport in human red blood cellsR B Gunn, M Dalmark, D C Tosteson, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
Phase I study of 4-demethoxydaunorubicin by oral route in patients with advanced cancerA Krarup-Hansen, E Andersen, K Elbaek, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1989
Oral idarubicin in the treatment of advanced breast cancerL Bastholt, M Dalmark, A Jakobsen, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1990
Weekly oral idarubicin in postmenopausal women with advanced breast cancer. A phase II studyL Bastholt, M Dalmark, A Jakobsen, et al.
Clinical Pharmacology and Therapeutics|June 1, 1989
Pharmacokinetics of oral idarubicin in breast cancer patients with reference to antitumor activity and side effectsK Elbaek, E Ebbehøj, A Jakobsen, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1993
A randomized feasibility study evaluating the effect of radiotherapy alone or combined with 5-fluorouracil in the treatment of locally recurrent or inoperable colorectal carcinomaM Overgaard, K Bertelsen, M Dalmark, et al.
Pageof 4